Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of metformin, pioglitazone, and silymarin on biochemical indices in NASH
IRCT201105084849N2Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin, pioglitazone and silymarin in metabolic dysfunction-associated steatohepatitis (MASH) (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Biochemical indices, AST and 1 more. Started Nov 2010; status: completed.
02
Drugs
metforminpioglitazonesilymarin
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on IRCT201105084849N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201105084849N2.